Health Care & Life Sciences » Pharmaceuticals | GlaxoSmithKline Consumer Healthcare Ltd.

GlaxoSmithKline Consumer Healthcare Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,161
8,891
10,560
6,567
7,001
Depreciation, Depletion & Amortization
625
621
574
642
644
Other Funds
3,807
2,873
4,154
457
1,174
Funds from Operations
6,979
6,639
6,980
6,752
6,471
Changes in Working Capital
650
1,201
534
1,242
2,615
Net Operating Cash Flow
7,630
7,840
7,514
7,994
9,086
Capital Expenditures
1,686
1,074
545
683
514
Sale of Fixed Assets & Businesses
11
18
24
26
20
Purchase/Sale of Investments
2,237
2,631
2,797
7,357
5,833
Net Investing Cash Flow
3,912
1,574
3,318
8,014
6,327
Cash Dividends Paid - Total
2,214
2,214
2,784
3,542
3,530
Issuance/Reduction of Debt, Net
-
-
49
44
84
Net Financing Cash Flow
2,214
2,214
2,833
3,585
3,614
Net Change in Cash
1,504
7,200
1,363
3,606
855
Free Cash Flow
5,944
6,766
6,969
7,311
8,572

About GlaxoSmithKline Consumer Healthcare

View Profile
Address
24 & 25 Floor, One Horizon Centre
Gurgaon Haryana 122002
India
Employees -
Website http://www.gsk-ch.in
Updated 09/14/2018
GlaxoSmithKline Consumer Healthcare Ltd. engages in the manufacture of nutritional products. Its products include Horlicks, Boost, Viva, Maltova, Ostocalcium, Otrivin, Sensodyne, Voltaren, ActiBase, ActiGrow, and Parodontax. The company was founded on October 30, 1958 and is headquartered in Gurgaon, India.